Multiple Insiders Sold Arteris Shares Presenting Weak Signs For Investors
Multiple Insiders Sold Arteris Shares Presenting Weak Signs For Investors
A number of Arteris, Inc. (NASDAQ:AIP) insiders sold their shares in the last year, which may have raised concerns among investors. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more.
过去一年里,Arteris, Inc.(纳斯达克:AIP)的一些内部人士出售了他们的股份,这可能引起了投资者的担忧。在评估内部交易时,了解内部人员是否在买入通常比了解他们是否在卖出更有益,因为后者可能有许多解读。但是,如果有许多内部人员在卖出,股东应该进行更深入的调查。
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
尽管在长期投资中内部交易并不是最重要的事情,但从逻辑上讲,您应该关注内部人员是否买入或出售股票。
Arteris Insider Transactions Over The Last Year
过去一年的Arteris内部交易
The Chairman, Karel Janac, made the biggest insider sale in the last 12 months. That single transaction was for US$71k worth of shares at a price of US$7.03 each. That means that an insider was selling shares at slightly below the current price (US$7.28). When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 0.1% of Karel Janac's holding.
董事长Karel Janac在过去12个月内进行了最大规模的内部交易。该笔交易总值为7.1万美元,每股价格为7.03美元。这意味着一名内部人员以略低于当前价格(7.28美元)的价格出售了股份。当内部人员以低于当前价格出售时,这表明他们认为较低的价格是公平的。这让我们想知道他们对(更高的)最近的估值持什么看法。但是,尽管内部人员的卖出有时令人沮丧,但这只是一个微弱的信号。值得注意的是,这笔交易仅占Karel Janac持股的0.1%。
Insiders in Arteris didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
Arteris的内部人士在过去一年内没有买入任何股票。您可以在下方看到上述时间内内部交易(由公司和个人)的视觉呈现。点击下方的图表,您可以查看每笔内部交易的详细信息!
I will like Arteris better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
如果我看到一些大的内部交易买入,我会更喜欢Artesis。在我们等待的时候,请查看这份免费的被低估的小盘股和近期有相当多内部交易买入的股票清单。
Arteris Insiders Are Selling The Stock
Artesis的内部人正在卖出股票
Over the last three months, we've seen significant insider selling at Arteris. In total, insiders sold US$126k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
在过去的三个月里,我们看到了Artesis有重要的内部卖出交易。在那个时间段内,内部人士共计卖出了12.6万美元,而我们没有记录到任何购买交易。总的来说,这使我们有些谨慎,但这并不是决定一切的因素。
Does Arteris Boast High Insider Ownership?
Artesis是否拥有很高的内部持股量?
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Arteris insiders own 32% of the company, worth about US$93m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
对于普通股东而言,值得检查公司内部持有多少股份。通常情况下,内部持股比例越高,内部人员在长期内建设公司的动力就越大。看起来,Arteris的内部人员拥有公司的32%股份,价值约9300万美元。在其他地方,我们确实看到了更高比例的内部持股,但这些持股足以表明内部人员与其他股东存在一定的利益一致性。
So What Do The Arteris Insider Transactions Indicate?
那么,Arteris内部交易显示了什么?
Insiders haven't bought Arteris stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own shares, they don't own a heap, and they have been selling. We're in no rush to buy! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. When we did our research, we found 4 warning signs for Arteris (1 is a bit concerning!) that we believe deserve your full attention.
内部人员在过去三个月没有买入Arteris股票,但有一些卖出。回顾过去12个月,我们的数据没有显示内部人员有任何买入行为。虽然内部人员拥有部分股份,但数额不大,而且他们一直在抛售。我们不着急买入!因此,这些内部交易可以帮助我们建立对该股的分析,但了解该公司面临的风险也同样重要。在进行了研究后,我们发现了4个Arteris的警示信号(其中1个令人有些担忧!)我们认为这值得您的充分关注。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
如果您想查看另一家公司的信息-一家潜在具有优秀财务状况的公司-请不要错过这个带有高股权回报率和低债务的有趣公司免费列表。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。